Cargando…
Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis
BACKGROUND: Controversy exists as to whether the threshold for blood pressure-lowering treatment should differ between people with and without type 2 diabetes. We aimed to investigate the effects of blood pressure-lowering treatment on the risk of major cardiovascular events by type 2 diabetes statu...
Autores principales: | Nazarzadeh, Milad, Bidel, Zeinab, Canoy, Dexter, Copland, Emma, Bennett, Derrick A, Dehghan, Abbas, Davey Smith, George, Holman, Rury R, Woodward, Mark, Gupta, Ajay, Adler, Amanda I, Wamil, Malgorzata, Sattar, Naveed, Cushman, William C, McManus, Richard J, Teo, Koon, Davis, Barry R, Chalmers, John, Pepine, Carl J, Rahimi, Kazem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Lancet, Diabetes & Endocrinology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622419/ https://www.ncbi.nlm.nih.gov/pubmed/35878651 http://dx.doi.org/10.1016/S2213-8587(22)00172-3 |
Ejemplares similares
-
Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis
por: Nazarzadeh, Milad, et al.
Publicado: (2021) -
Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis
por: Copland, Emma, et al.
Publicado: (2021) -
How Much Lowering of Blood Pressure Is Required to Prevent Cardiovascular Disease in Patients With and Without Previous Cardiovascular Disease?
por: Canoy, Dexter, et al.
Publicado: (2022) -
Stratification of diabetes in the context of comorbidities, using representation learning and topological data analysis
por: Wamil, Malgorzata, et al.
Publicado: (2023) -
Investigating the stratified efficacy and safety of pharmacological blood pressure-lowering: an overall protocol for individual patient-level data meta-analyses of over 300 000 randomised participants in the new phase of the Blood Pressure Lowering Treatment Trialists’ Collaboration (BPLTTC)
por: Rahimi, Kazem, et al.
Publicado: (2019)